English
Background Viruses are obligatory intracellular parasites that manipulate the host cell machinery for propagation. The large group of positive-strand RNA viruses includes many human pathogens such as enteroviruses, hepatitis C virus, dengue virus, and SARS-coronavirus. All positive-strand RNA viruses reorganize host cell membranes into "replication organelles" on which viral RNA (vRNA) replication takes place. Recently, we were the first to resolve the three-dimensional structure of the enterovirus replication organelles. The membrane modifications were detected in the exponential phase of vRNA replication and consisted of cytosolic tubular membrane structures. However, the ultrastructure of the initial membrane modifications at the onset of vRNA replication as well as the identity of the donor organelle have remained elusive. Furthermore, it is largely unknown which host machinery is exploited by enteroviruses to form their replication organelles. Recently, I performed the first genome-wide RNAi screen on enteroviruses to reveal novel host factors crucial for replication. Intriguingly, among the hits were several factors that regulate membrane bending, vesicle formation, and membrane fusion. Since replication organelle formation also involves these processes, I postulate that enteroviruses hijack these factors to build their replication organelles. Aim and approach This project aims to (1) elucidate the three-dimensional structure of the initial enterovirus-induced modifications and to reveal the identity of the donor organelle, and (2) decipher the role of the novel host factors identified in my genome-wide screen in replication organelle formation. To this end, I propose an integrated approach involving state-of-the-art virological, molecular, biochemical, and microscopy techniques. Importance Enteroviruses comprise a large group of medically and economically important human pathogens, for which no licensed antiviral therapy is available. This project will generate important new insights into how enteroviruses build their replication organelles. Furthermore, the identification of novel host factors essential for this process will provide new targets for antiviral drug development.
